These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 29298992)

  • 1. Germline variants in IL4, MGMT and AKT1 are associated with prostate cancer-specific mortality: An analysis of 12,082 prostate cancer cases.
    FitzGerald LM; Zhao S; Leonardson A; Geybels MS; Kolb S; Lin DW; Wright JL; Eeles R; Kote-Jarai Z; Govindasami K; Giles GG; Southey MC; Schleutker J; Tammela TL; Sipeky C; Penney KL; Stampfer MJ; Gronberg H; Wiklund F; Stattin P; Hugosson J; Karyadi DM; Ostrander EA; Feng Z; Stanford JL
    Prostate Cancer Prostatic Dis; 2018 Jun; 21(2):228-237. PubMed ID: 29298992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostate cancer (PCa) risk variants and risk of fatal PCa in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium.
    Shui IM; Lindström S; Kibel AS; Berndt SI; Campa D; Gerke T; Penney KL; Albanes D; Berg C; Bueno-de-Mesquita HB; Chanock S; Crawford ED; Diver WR; Gapstur SM; Gaziano JM; Giles GG; Henderson B; Hoover R; Johansson M; Le Marchand L; Ma J; Navarro C; Overvad K; Schumacher FR; Severi G; Siddiq A; Stampfer M; Stevens VL; Travis RC; Trichopoulos D; Vineis P; Mucci LA; Yeager M; Giovannucci E; Kraft P
    Eur Urol; 2014 Jun; 65(6):1069-75. PubMed ID: 24411283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Confirmation of genetic variants associated with lethal prostate cancer in a cohort of men from hereditary prostate cancer families.
    Karyadi DM; Zhao S; He Q; McIntosh L; Wright JL; Ostrander EA; Feng Z; Stanford JL
    Int J Cancer; 2015 May; 136(9):2166-71. PubMed ID: 25273821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic variants in the LEPR, CRY1, RNASEL, IL4, and ARVCF genes are prognostic markers of prostate cancer-specific mortality.
    Lin DW; FitzGerald LM; Fu R; Kwon EM; Zheng SL; Kolb S; Wiklund F; Stattin P; Isaacs WB; Xu J; Ostrander EA; Feng Z; Grönberg H; Stanford JL
    Cancer Epidemiol Biomarkers Prev; 2011 Sep; 20(9):1928-36. PubMed ID: 21846818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An
    Furini HH; Fukushima KSSQ; DE Nóbrega M; DE Souza MF; Rodrigues MRS; DE Mattos BB; Guembarovski RL; Fuganti PE; Simão ANC; Flauzino T; Cólus IMS
    Anticancer Res; 2023 Jan; 43(1):369-379. PubMed ID: 36585213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Replication of a genetic variant for prostate cancer-specific mortality.
    Penney KL; Shui IM; Feng Z; Sesso HD; Stampfer MJ; Stanford JL
    Prostate Cancer Prostatic Dis; 2015 Sep; 18(3):260-3. PubMed ID: 25939514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MGMT germline polymorphism is associated with somatic MGMT promoter methylation and gene silencing in colorectal cancer.
    Ogino S; Hazra A; Tranah GJ; Kirkner GJ; Kawasaki T; Nosho K; Ohnishi M; Suemoto Y; Meyerhardt JA; Hunter DJ; Fuchs CS
    Carcinogenesis; 2007 Sep; 28(9):1985-90. PubMed ID: 17621591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Role of O
    Zhang W; Liu M; Li Y; Song S; Li K; Ma Y
    Pathol Oncol Res; 2020 Apr; 26(2):1201-1209. PubMed ID: 31190217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The risk of prostate cancer mortality and cardiovascular mortality of nonmetastatic prostate cancer patients: A population-based retrospective cohort study.
    Matthes KL; Pestoni G; Korol D; Van Hemelrijck M; Rohrmann S
    Urol Oncol; 2018 Jun; 36(6):309.e15-309.e23. PubMed ID: 29576269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radical prostatectomy in Denmark: Survival analysis and temporal trends in clinicopathological parameters with up to 20 years of follow-up.
    Heering M; Berg KD; Brasso K; Iversen P; Røder MA
    Surg Oncol; 2017 Mar; 26(1):21-27. PubMed ID: 28317581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MGMT Ile143Val polymorphism, dietary factors and the risk of breast, colorectal and prostate cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC)-Norfolk study.
    Loh YH; Mitrou PN; Bowman R; Wood A; Jeffery H; Luben RN; Lentjes MA; Khaw KT; Rodwell SA
    DNA Repair (Amst); 2010 Apr; 9(4):421-8. PubMed ID: 20096652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Germline Variants in DNA Repair Genes, Diagnostic Radiation, and Risk of Thyroid Cancer.
    Sandler JE; Huang H; Zhao N; Wu W; Liu F; Ma S; Udelsman R; Zhang Y
    Cancer Epidemiol Biomarkers Prev; 2018 Mar; 27(3):285-294. PubMed ID: 29263185
    [No Abstract]   [Full Text] [Related]  

  • 13. Single-nucleotide polymorphisms in DNMT3B gene and DNMT3B mRNA expression in association with prostate cancer mortality.
    Zelic R; Fiano V; Ebot EM; Coseo Markt S; Grasso C; Trevisan M; De Marco L; Delsedime L; Zugna D; Mucci LA; Richiardi L
    Prostate Cancer Prostatic Dis; 2019 May; 22(2):284-291. PubMed ID: 30341411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A five-miRNA signature with prognostic and predictive value for MGMT promoter-methylated glioblastoma patients.
    Cheng W; Ren X; Cai J; Zhang C; Li M; Wang K; Liu Y; Han S; Wu A
    Oncotarget; 2015 Oct; 6(30):29285-95. PubMed ID: 26320189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variation in selenoenzyme genes and prostate cancer risk and survival.
    Geybels MS; Hutter CM; Kwon EM; Ostrander EA; Fu R; Feng Z; Stanford JL; Peters U
    Prostate; 2013 May; 73(7):734-42. PubMed ID: 23143801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lycopene, tomato products and prostate cancer-specific mortality among men diagnosed with nonmetastatic prostate cancer in the Cancer Prevention Study II Nutrition Cohort.
    Wang Y; Jacobs EJ; Newton CC; McCullough ML
    Int J Cancer; 2016 Jun; 138(12):2846-55. PubMed ID: 26830232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improving Clinical Risk Stratification at Diagnosis in Primary Prostate Cancer: A Prognostic Modelling Study.
    Gnanapragasam VJ; Lophatananon A; Wright KA; Muir KR; Gavin A; Greenberg DC
    PLoS Med; 2016 Aug; 13(8):e1002063. PubMed ID: 27483464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognosis value of MGMT promoter methylation for patients with lung cancer: a meta-analysis.
    Chen C; Hua H; Han C; Cheng Y; Cheng Y; Wang Z; Bao J
    Int J Clin Exp Pathol; 2015; 8(9):11560-4. PubMed ID: 26617891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human TERT promoter mutation enables survival advantage from MGMT promoter methylation in IDH1 wild-type primary glioblastoma treated by standard chemoradiotherapy.
    Nguyen HN; Lie A; Li T; Chowdhury R; Liu F; Ozer B; Wei B; Green RM; Ellingson BM; Wang HJ; Elashoff R; Liau LM; Yong WH; Nghiemphu PL; Cloughesy T; Lai A
    Neuro Oncol; 2017 Mar; 19(3):394-404. PubMed ID: 27571882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recreational Physical Activity in Relation to Prostate Cancer-specific Mortality Among Men with Nonmetastatic Prostate Cancer.
    Wang Y; Jacobs EJ; Gapstur SM; Maliniak ML; Gansler T; McCullough ML; Stevens VL; Patel AV
    Eur Urol; 2017 Dec; 72(6):931-939. PubMed ID: 28711382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.